Table of Content

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunodiagnostics Market – by Product
1.3.2 Global Immunodiagnostics Market – by Clinical Indication
1.3.3 Global Immunodiagnostics Market – by End User
1.3.4 Global Immunodiagnostics Market – by Geography

2. Immunodiagnostics Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Immunodiagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.2.6 South & Central America PEST Analysis
4.3 Expert’s Opinion

5. Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market – Global Analysis
6.1 Global Immunodiagnostics Market Revenue Forecast and Analysis
6.2 Global Immunodiagnostics Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players

7. Immunodiagnostics Market Analysis – by Product
7.1 Overview
7.2 Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Immunodiagnostics Market Analysis – Clinical Indication
8.1 Overview
8.2 Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Immunodiagnostics Market Analysis – End User
9.1 Overview
9.2 Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Immunodiagnostics Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Immunodiagnostics Market
10.1.1 Overview
10.1.2 North America: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.4 North America: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.1.4.1 North America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.4.2 North America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5 North America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.1 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4 US: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.1 US: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.2 US: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.5 US: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4 Canada: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.1 Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.2 Canada: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.5 Canada: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4 Mexico: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.1 Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.2 Mexico: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.5 Mexico: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2 Europe: Immunodiagnostics Market
10.2.1 Overview
10.2.2 Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.4 Europe: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.2.4.1 Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.4.2 Europe: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5 Europe: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.1 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.1 Overview
10.2.5.1.2 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.3 UK: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.1.3.1 UK: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4 UK: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.1 UK: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.2 UK: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.5 UK: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.1 Overview
10.2.5.2.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.3 Germany: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.2.3.1 Germany: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4 Germany: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.1 Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.2 Germany: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.5 Germany: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.3 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.1 Overview
10.2.5.3.2 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.3 France: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.3.3.1 France: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4 France: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.1 France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.2 France: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.5 France: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.4 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.1 Overview
10.2.5.4.2 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.3 Italy: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.4.3.1 Italy: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4 Italy: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.1 Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.2 Italy: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.5 Italy: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.5 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.1 Overview
10.2.5.5.2 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.3 Spain: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.5.3.1 Spain: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4 Spain: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.1 Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.2 Spain: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.5 Spain: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.6 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.1 Overview
10.2.5.6.2 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.3 Rest of Europe: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.6.3.1 Rest of Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4 Rest of Europe: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.1 Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.2 Rest of Europe: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.5 Rest of Europe: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3 Asia Pacific: Immunodiagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.4 Asia Pacific: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.4.2 Asia Pacific: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5 Asia Pacific: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.1 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.1 Overview
10.3.5.1.2 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.3 China: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.1.3.1 China: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4 China: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.1 China: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.2 China: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.5 China: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.1 Overview
10.3.5.2.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.3 Japan: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.2.3.1 Japan: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4 Japan: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.1 Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.2 Japan: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.5 Japan: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.3 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.1 Overview
10.3.5.3.2 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.3 India: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.3.3.1 India: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4 India: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.1 India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.2 India: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.5 India: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.4 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.1 Overview
10.3.5.4.2 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.3 Australia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.4.3.1 Australia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4 Australia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.1 Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.2 Australia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.5 Australia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.5 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.1 Overview
10.3.5.5.2 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.3 South Korea: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.5.3.1 South Korea: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4 South Korea: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.1 South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.2 South Korea: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.5 South Korea: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.6 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.1 Overview
10.3.5.6.2 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.3 Rest of Asia Pacific: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.6.3.1 Rest of Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4 Rest of Asia Pacific: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.1 Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.2 Rest of Asia Pacific: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.5 Rest of Asia Pacific: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4 Middle East & Africa: Immunodiagnostics Market
10.4.1 Overview
10.4.2 Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.4 Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.4.2 Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5 Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.1 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 UAE: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 UAE: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4 UAE: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.1 UAE: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.2 UAE: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.5 UAE: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.3 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 South Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 South Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4 South Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.1 South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.2 South Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.5 South Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5 South & Central America: Immunodiagnostics Market
10.5.1 Overview
10.5.2 South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.4 South & Central America: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.5.4.2 South & Central America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.5.5 South & Central America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5.5.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.1 Overview
10.5.5.1.2 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.3 Brazil: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.5.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4.1 Brazil: Immunodiagnos

List of Figures

LIST OF FIGURES

Figure 1. Immunodiagnostics Market Segmentation
Figure 2. Immunodiagnostics Market, by Region
Figure 3. Global Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Immunodiagnostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Immunodiagnostics Market, by Geography (US$ Million)
Figure 7. Global Immunodiagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Immunodiagnostics Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030
Figure 17. Global Immunodiagnostics Market, by Geography – Forecast and Analysis (2020–2028)
Figure 18. Market Positioning of Key Players in Immunodiagnostics Market
Figure 19. Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 20. Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 29. Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 33. Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Gastrointestinal: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 42. Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 43. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 44. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 45. Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 46. Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 47. Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 49. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 50. Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 51. Hospitals: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 52. Clinics: Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 53. Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 54. Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 55. Others: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 56. North America: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 57. North America Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. North America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 59. US: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. Europe: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 63. Europe Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 65. UK: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 66. Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 67. France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 68. Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 69. Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 70. Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 71. Asia Pacific: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 72. Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 74. China: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 75. Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 76. India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 77. Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 78. South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 79. Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 80. Middle East & Africa: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 81. Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 82. Middle East & Africa: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 83. UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 84. Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 85. South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 86. Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 87. South & Central America: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 88. South & Central America Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 89. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 90. Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 91. Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 92. Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 93. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 94. Impact of COVID-19 Pandemic on European Countries Markets
Figure 95. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 96. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 97. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 98. Growth Strategies in the Immunodiagnostics Market

List of Tables

LIST OF TABLES

Table 1. Infectious Diseases and Funding
Table 2. North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 10. US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 32. UK Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 38. Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 44. France Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 46. France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 47. France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 48. France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 49. France Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 62. Rest of Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 74. China Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 76. China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 86. India Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 88. India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 89. India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 99. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 103. South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 110. Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 116. UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 117. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 118. UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 119. UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 120. UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 121. UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 124. Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 125. Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 126. Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 127. Saudi Arabia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 128. South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 129. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 140. South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 141. South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 146. Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 147. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 152. Argentina Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 153. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 158. Rest of South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 159. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 164. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 165. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 166. Glossary of Terms, Immunodiagnostics Market